GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
1.090
-0.005 (-0.46%)
At close: Mar 20, 2026, 4:00 PM EDT
1.066
-0.024 (-2.19%)
After-hours: Mar 20, 2026, 7:02 PM EDT
GlucoTrack Employees
GlucoTrack had 11 employees as of December 31, 2024. The number of employees increased by 5 or 83.33% compared to the previous year.
Employees
11
Change (1Y)
5
Growth (1Y)
83.33%
Revenue / Employee
n/a
Profits / Employee
-$2,350,364
Market Cap
992.65K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 11 | 5 | 83.33% | 11 | 0 |
| Dec 31, 2023 | 6 | 3 | 100.00% | 6 | 0 |
| Dec 31, 2022 | 3 | -2 | -40.00% | 3 | 0 |
| Dec 31, 2021 | 5 | -6 | -54.55% | 5 | 0 |
| Dec 31, 2020 | 11 | 4 | 57.14% | 11 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Jin Medical International | 273 |
| Retractable Technologies | 227 |
| Bionano Genomics | 100 |
| Precision Optics Corporation | 90 |
| Femasys | 71 |
| Ekso Bionics Holdings | 55 |
| Nephros | 31 |
| NEXGEL | 19 |
GCTK News
- 11 days ago - Glucotrack to Present at LSI USA '26 Medtech Innovation Summit - GlobeNewsWire
- 7 weeks ago - Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform - GlobeNewsWire
- 2 months ago - Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor - GlobeNewsWire
- 4 months ago - Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights - GlobeNewsWire
- 4 months ago - Glucotrack, Inc. Encourages Shareholders to Vote - GlobeNewsWire
- 5 months ago - Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team - GlobeNewsWire
- 5 months ago - Glucotrack, Inc. Reminds Shareholders to Vote - GlobeNewsWire
- 6 months ago - Glucotrack to Participate in the Q3 Virtual Investor Summit - GlobeNewsWire